1. Home
  2. INDI vs RGNX Comparison

INDI vs RGNX Comparison

Compare INDI & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo indie Semiconductor Inc.

INDI

indie Semiconductor Inc.

HOLD

Current Price

$1.59

Market Cap

760.6M

Sector

Technology

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$6.58

Market Cap

793.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDI
RGNX
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
760.6M
793.5M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
INDI
RGNX
Price
$1.59
$6.58
Analyst Decision
Buy
Buy
Analyst Count
8
12
Target Price
$5.28
★ $23.58
AVG Volume (30 Days)
★ 5.5M
1.3M
Earning Date
11-05-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
3.95
★ 18.08
EPS
★ N/A
N/A
Revenue
★ $217,394,000.00
$10,393,000.00
Revenue This Year
$22.61
N/A
Revenue Next Year
$33.22
$23.50
P/E Ratio
N/A
★ N/A
Revenue Growth
0.33
★ 126.48
52 Week Low
$1.54
$5.46
52 Week High
$5.97
$16.19

Technical Indicators

Market Signals
Indicator
INDI
RGNX
Relative Strength Index (RSI) 16.04 34.87
Support Level N/A $5.67
Resistance Level $3.32 $7.32
Average True Range (ATR) 0.14 0.46
MACD -0.04 -0.01
Stochastic Oscillator 6.64 2.73

Price Performance

Historical Comparison
INDI
RGNX

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc caters to the autotech industry with semiconductors, photonics, and software platforms. The company's products include devices for a multitude of automotive applications spanning vision and radar processors, in-cabin wireless charging and USB power delivery, device interfacing through Apple CarPlay and Android Auto, and high-speed video and data connectivity. New products under evaluation or development include LiDAR, cybersecurity-enabled microcontrollers, and sensor-fusion processors. Its Photonics division mainly offers low-noise lasers, standard, and custom light sources. Geographically, the company generates the majority of its revenue from Greater China and the rest from the United States, Europe, South Korea, and other regions.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: